EYPT earnings date and last-quarter result: last quarter miss, P/E -3.62. Updated 2026-07-23.
EyePoint Pharmaceuticals (EYPT) Research Hub
EyePoint Pharmaceuticals (EYPT) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 0.3657 USD (-9.59%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -3.62, market cap 1.05B. This hub links to the full technical, earnings and options research available for EYPT.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.3657 USD (-9.59%) |
| 52-week range | 0.3626 USD – 15.38 USD |
| Trend regime | Range |
| 14-day RSI | 12 (Oversold) |
| Trailing P/E | -3.62 |
| Market cap | 1.05B |
| Dividend yield | 0.00% |
Available research for EYPT
Covered Call on EYPT: how it works, illustrative setup around the real 0.3657 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on EYPT: how it works, illustrative setup around the real 0.3657 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on EYPT: how it works, illustrative setup around the real 0.3657 USD price, max profit/loss, breakeven and when to use it. Educational.
EYPT technical analysis: range, last 0.3657 USD, RSI 12, 52w range 0.3626 USD–15.38 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is EYPT in?
EyePoint Pharmaceuticals (EYPT) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is EYPT in an uptrend or downtrend?
As of 2026-10-26, EYPT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is EYPT's trailing P/E ratio?
EYPT's trailing P/E is -3.62, with a market cap of 1.05B. See the earnings research page for full valuation detail.